Virology and Viral Diseases Market Analysis and Reports | Canada Conference Series

Market Analysis - Virology And Viral Diseases 2018

Market Analysis

The major players are expected to remain key growth drivers for virology over the study period because of increased instances of viral epidemic breakouts and huge investment in Research and Development. Our virology conference is bringing experts from the field of virology for discussion of the latest advances and ideas and to stimulate interdisciplinary interactions. Conference like ours will help to speed up of the development of effective therapies for viral disorders.

Virology Market: Segmentation

Virology Market is segmented By Applications into Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections. STDs, Urinary tract infections, and respiratory tract infections are currently dominating as compared to the other application types in the global virology market. Virology Market is segmented By End Users into Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies.

Current Trends in the Virology Field

  • In 2015, the virology industry was predominantly influenced by Ebola, MERS, and hepatitis C viruses. In 2016, zika virus is dominating the research, with better prospects in the near future.
  • Virologists are persistently investigating novel applications for viruses. Currently, an on-going research is experimenting on the exploitation of viruses for plant production, aiming at the efficient production of high quality, eco-friendly food.

Regional Outlook: Global Virology Market

  • North America is the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. N. America is expected to retain the top market position over the forecast period as well.
  • Europe is projected to maintain the position as the second largest market globally. During the forecast period, Europe is anticipated to record the highest CAGR, attributed by enhanced healthcare infrastructure, facilitated access to diagnostics, and growing affordability of diagnostic tests for viral diseases.
  • Japan is currently a growing virology market, which is estimated to grow at a remarkable CAGR through to 2025. However, APEJ and Africa are expected to witness the most promising growth opportunities during the forecast period. While China will be a leading APEJ market, India will contribute a considerable revenue share to the APEJ virology market.

Segment-wise Market Forecast

  • Antiviral drugs are the fastest-growing market segments in the estimated forecast period.
  • STDs, urinary tract infections, and respiratory tract infections are currently dominating compared to other application types in the global virology market.
  • On the basis of diagnosis tests, hepatitis B, hepatitis C, HIV, human papillomavirus (HPV), and other tests (influenza, ebola, and dengue) are estimated to attract the largest market shares globally.
  • Hospitals and laboratories projected to continue the most dominating end-use segments, accounting for almost 50% market share globally.

Key Players in the Global Virology Market

  • The notable players identified in the global virology market include GlaxoSmithKline , Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.
  • Merck and Co. Inc. has several drug candidates in phase 2, including cancer, diabetes, cardiac arrest, and hepatitis C, and some candidates in phase 3, including breast cancer, atherosclerosis, Alzeimer's, ebola, and HIV. The company also has many other candidates, which are currently under review.
  • Abivax, a high profile biotech company in Paris, France, has already successfully produced candidates against dengue and chikungunya viruses. The company has a few more candidates against HIV and ebola, currently under development.